United States Next Generation Cancer Diagnostic Devices Market Report & Forecast 2021-2027

United States Next Generation Cancer Diagnostic Devices Market Report & Forecast 2021-2027

Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Next Generation Cancer Diagnostic Devices Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 United States Next Generation Cancer Diagnostic Devices Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 United States Next Generation Cancer Diagnostic Devices Overall Market Size
2.1 United States Next Generation Cancer Diagnostic Devices Market Size: 2021 VS 2027
2.2 United States Next Generation Cancer Diagnostic Devices Revenue, Prospects & Forecasts: 2016-2027
2.3 United States Next Generation Cancer Diagnostic Devices Sales: 2016-2027
3 Company Landscape
3.1 Top Next Generation Cancer Diagnostic Devices Players in United States Market
3.2 Top United States Next Generation Cancer Diagnostic Devices Companies Ranked by Revenue
3.3 United States Next Generation Cancer Diagnostic Devices Revenue by Companies
3.4 United States Next Generation Cancer Diagnostic Devices Sales by Companies
3.5 United States Next Generation Cancer Diagnostic Devices Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Next Generation Cancer Diagnostic Devices Companies in United States Market, by Revenue in 2020
3.7 Manufacturers Next Generation Cancer Diagnostic Devices Product Type
3.8 Tier 1, Tier 2 and Tier 3 Next Generation Cancer Diagnostic Devices Players in United States Market
3.8.1 List of Tier 1 Next Generation Cancer Diagnostic Devices Companies in United States
3.8.2 List of Tier 2 and Tier 3 Next Generation Cancer Diagnostic Devices Companies in United States
4 Sights by Type
4.1 Overview
4.1.1 By Type - United States Next Generation Cancer Diagnostic Devices Market Size Markets, 2021 & 2027
4.1.2 Next Generation Sequencing
4.1.3 qPCR & Multiplexing
4.1.4 Lab-on- a- chip (LOAC)
4.1.5 Protein Microarrays
4.1.6 DNA Microarrays
4.1.7 Reverse Transcriptase-PCR (RT-PCR)
4.2 By Type - United States Next Generation Cancer Diagnostic Devices Revenue & Forecasts
4.2.1 By Type - United States Next Generation Cancer Diagnostic Devices Revenue, 2016-2021
4.2.2 By Type - United States Next Generation Cancer Diagnostic Devices Revenue, 2022-2027
4.2.3 By Type - United States Next Generation Cancer Diagnostic Devices Revenue Market Share, 2016-2027
4.3 By Type - United States Next Generation Cancer Diagnostic Devices Sales & Forecasts
4.3.1 By Type - United States Next Generation Cancer Diagnostic Devices Sales, 2016-2021
4.3.2 By Type - United States Next Generation Cancer Diagnostic Devices Sales, 2022-2027
4.3.3 By Type - United States Next Generation Cancer Diagnostic Devices Sales Market Share, 2016-2027
4.4 By Type - United States Next Generation Cancer Diagnostic Devices Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - United States Next Generation Cancer Diagnostic Devices Market Size, 2021 & 2027
5.1.2 Biomarker Development
5.1.3 CTC Analysis
5.1.4 Proteomic Analysis
5.1.5 Epigenetic Analysis
5.1.6 Genetic Analysis
5.2 By Application - United States Next Generation Cancer Diagnostic Devices Revenue & Forecasts
5.2.1 By Application - United States Next Generation Cancer Diagnostic Devices Revenue, 2016-2021
5.2.2 By Application - United States Next Generation Cancer Diagnostic Devices Revenue, 2022-2027
5.2.3 By Application - United States Next Generation Cancer Diagnostic Devices Revenue Market Share, 2016-2027
5.3 By Application - United States Next Generation Cancer Diagnostic Devices Sales & Forecasts
5.3.1 By Application - United States Next Generation Cancer Diagnostic Devices Sales, 2016-2021
5.3.2 By Application - United States Next Generation Cancer Diagnostic Devices Sales, 2022-2027
5.3.3 By Application - United States Next Generation Cancer Diagnostic Devices Sales Market Share, 2016-2027
5.4 By Application - United States Next Generation Cancer Diagnostic Devices Price (Manufacturers Selling Prices), 2016-2027
6 Manufacturers & Brands Profiles
6.1 Roche Holding Ltd.?Switzerland)
6.1.1 Roche Holding Ltd.?Switzerland) Corporation Information
6.1.2 Roche Holding Ltd.?Switzerland) Overview
6.1.3 Roche Holding Ltd.?Switzerland) Next Generation Cancer Diagnostic Devices Sales and Revenue in United States Market (2016-2021)
6.1.4 Roche Holding Ltd.?Switzerland) Next Generation Cancer Diagnostic Devices Product Description
6.1.5 Roche Holding Ltd.?Switzerland) Recent Developments
6.2 Abbott Laboratories(US)
6.2.1 Abbott Laboratories(US) Corporation Information
6.2.2 Abbott Laboratories(US) Overview
6.2.3 Abbott Laboratories(US) Next Generation Cancer Diagnostic Devices Sales and Revenue in United States Market (2016-2021)
6.2.4 Abbott Laboratories(US) Next Generation Cancer Diagnostic Devices Product Description
6.2.5 Abbott Laboratories(US) Recent Developments
6.3 Siemens Healthcare(Germany)
6.3.1 Siemens Healthcare(Germany) Corporation Information
6.3.2 Siemens Healthcare(Germany) Overview
6.3.3 Siemens Healthcare(Germany) Next Generation Cancer Diagnostic Devices Sales and Revenue in United States Market (2016-2021)
6.3.4 Siemens Healthcare(Germany) Next Generation Cancer Diagnostic Devices Product Description
6.3.5 Siemens Healthcare(Germany) Recent Developments
6.4 Agilent Technologies Inc(Germany)
6.4.1 Agilent Technologies Inc(Germany) Corporation Information
6.4.2 Agilent Technologies Inc(Germany) Overview
6.4.3 Agilent Technologies Inc(Germany) Next Generation Cancer Diagnostic Devices Sales and Revenue in United States Market (2016-2021)
6.4.4 Agilent Technologies Inc(Germany) Next Generation Cancer Diagnostic Devices Product Description
6.4.5 Agilent Technologies Inc(Germany) Recent Developments
6.5 Illumina Inc.(US)
6.5.1 Illumina Inc.(US) Corporation Information
6.5.2 Illumina Inc.(US) Overview
6.5.3 Illumina Inc.(US) Next Generation Cancer Diagnostic Devices Sales and Revenue in United States Market (2016-2021)
6.5.4 Illumina Inc.(US) Next Generation Cancer Diagnostic Devices Product Description
6.5.5 Illumina Inc.(US) Recent Developments
6.6 Becton Dickinson and Co.(US)
6.6.1 Becton Dickinson and Co.(US) Corporation Information
6.6.2 Becton Dickinson and Co.(US) Overview
6.6.3 Becton Dickinson and Co.(US) Next Generation Cancer Diagnostic Devices Sales and Revenue in United States Market (2016-2021)
6.6.4 Becton Dickinson and Co.(US) Next Generation Cancer Diagnostic Devices Product Description
6.6.5 Becton Dickinson and Co.(US) Recent Developments
6.7 QIAGEN N.V.(Germany)
6.7.1 QIAGEN N.V.(Germany) Corporation Information
6.7.2 QIAGEN N.V.(Germany) Overview
6.7.3 QIAGEN N.V.(Germany) Next Generation Cancer Diagnostic Devices Sales and Revenue in United States Market (2016-2021)
6.7.4 QIAGEN N.V.(Germany) Next Generation Cancer Diagnostic Devices Product Description
6.7.5 QIAGEN N.V.(Germany) Recent Developments
6.8 Affymetrix Inc.(US)
6.8.1 Affymetrix Inc.(US) Corporation Information
6.8.2 Affymetrix Inc.(US) Overview
6.8.3 Affymetrix Inc.(US) Next Generation Cancer Diagnostic Devices Sales and Revenue in United States Market (2016-2021)
6.8.4 Affymetrix Inc.(US) Next Generation Cancer Diagnostic Devices Product Description
6.8.5 Affymetrix Inc.(US) Recent Developments
6.9 Johnson & Johnson(US)
6.9.1 Johnson & Johnson(US) Corporation Information
6.9.2 Johnson & Johnson(US) Overview
6.9.3 Johnson & Johnson(US) Next Generation Cancer Diagnostic Devices Sales and Revenue in United States Market (2016-2021)
6.9.4 Johnson & Johnson(US) Next Generation Cancer Diagnostic Devices Product Description
6.9.5 Johnson & Johnson(US) Recent Developments
6.10 Thermo Fisher Scientific Inc.(US)
6.10.1 Thermo Fisher Scientific Inc.(US) Corporation Information
6.10.2 Thermo Fisher Scientific Inc.(US) Overview
6.10.3 Thermo Fisher Scientific Inc.(US) Next Generation Cancer Diagnostic Devices Sales and Revenue in United States Market (2016-2021)
6.10.4 Thermo Fisher Scientific Inc.(US) Next Generation Cancer Diagnostic Devices Product Description
6.10.5 Thermo Fisher Scientific Inc.(US) Recent Developments
6.11 GE Healthcare(England)
6.11.1 GE Healthcare(England) Corporation Information
6.11.2 GE Healthcare(England) Overview
6.11.3 GE Healthcare(England) Next Generation Cancer Diagnostic Devices Sales and Revenue in United States Market (2016-2021)
6.11.4 GE Healthcare(England) Next Generation Cancer Diagnostic Devices Product Description
6.11.5 GE Healthcare(England) Recent Developments
6.12 Life Technologies Corp.(US)
6.12.1 Life Technologies Corp.(US) Corporation Information
6.12.2 Life Technologies Corp.(US) Overview
6.12.3 Life Technologies Corp.(US) Next Generation Cancer Diagnostic Devices Sales and Revenue in United States Market (2016-2021)
6.12.4 Life Technologies Corp.(US) Next Generation Cancer Diagnostic Devices Product Description
6.12.5 Life Technologies Corp.(US) Recent Developments
6.13 Luminex Corp.(US)
6.13.1 Luminex Corp.(US) Corporation Information
6.13.2 Luminex Corp.(US) Overview
6.13.3 Luminex Corp.(US) Next Generation Cancer Diagnostic Devices Sales and Revenue in United States Market (2016-2021)
6.13.4 Luminex Corp.(US) Next Generation Cancer Diagnostic Devices Product Description
6.13.5 Luminex Corp.(US) Recent Developments
6.14 Cepheid Inc.(US)
6.14.1 Cepheid Inc.(US) Corporation Information
6.14.2 Cepheid Inc.(US) Overview
6.14.3 Cepheid Inc.(US) Next Generation Cancer Diagnostic Devices Sales and Revenue in United States Market (2016-2021)
6.14.4 Cepheid Inc.(US) Next Generation Cancer Diagnostic Devices Product Description
6.14.5 Cepheid Inc.(US) Recent Developments
6.15 Allegro Diagnostics Corp.(Brazil)
6.15.1 Allegro Diagnostics Corp.(Brazil) Corporation Information
6.15.2 Allegro Diagnostics Corp.(Brazil) Overview
6.15.3 Allegro Diagnostics Corp.(Brazil) Next Generation Cancer Diagnostic Devices Sales and Revenue in United States Market (2016-2021)
6.15.4 Allegro Diagnostics Corp.(Brazil) Next Generation Cancer Diagnostic Devices Product Description
6.15.5 Allegro Diagnostics Corp.(Brazil) Recent Developments
7 United States Next Generation Cancer Diagnostic Devices Production Capacity, Analysis
7.1 United States Next Generation Cancer Diagnostic Devices Production Capacity, 2016-2027
7.2 Next Generation Cancer Diagnostic Devices Production Capacity of Key Manufacturers in United States Market
8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints
9 Next Generation Cancer Diagnostic Devices Supply Chain Analysis
9.1 Next Generation Cancer Diagnostic Devices Industry Value Chain
9.2 Next Generation Cancer Diagnostic Devices Upstream Market
9.3 Next Generation Cancer Diagnostic Devices Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Next Generation Cancer Diagnostic Devices Distributors and Sales Agents in United States Market
10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer
List of Tables
Table 1. Key Players of Next Generation Cancer Diagnostic Devices in United States Market
Table 2. Top Next Generation Cancer Diagnostic Devices Players in United States Market, Ranking by Revenue (2019)
Table 3. United States Next Generation Cancer Diagnostic Devices Revenue by Companies, (US$, Mn), 2016-2021
Table 4. United States Next Generation Cancer Diagnostic Devices Revenue Share by Companies, 2016-2021
Table 5. United States Next Generation Cancer Diagnostic Devices Sales by Companies, (K Pcs), 2016-2021
Table 6. United States Next Generation Cancer Diagnostic Devices Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Next Generation Cancer Diagnostic Devices Price (2016-2021) & (USD/Pcs)
Table 8. Manufacturers Next Generation Cancer Diagnostic Devices Product Type
Table 9. List of Tier 1 Next Generation Cancer Diagnostic Devices Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Next Generation Cancer Diagnostic Devices Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. Major Manufacturers of Next Generation Sequencing
Table 12. Major Manufacturers of qPCR & Multiplexing
Table 13. By Type - United States Next Generation Cancer Diagnostic Devices Revenue, (US$, Mn), 2021 & 2027
Table 14. By Type - United States Next Generation Cancer Diagnostic Devices Revenue (US$, Mn), 2016-2021
Table 15. By Type - United States Next Generation Cancer Diagnostic Devices Revenue (US$, Mn), 2022-2027
Table 16. By Type - United States Next Generation Cancer Diagnostic Devices Sales (K Pcs), 2016-2021
Table 17. By Type - United States Next Generation Cancer Diagnostic Devices Sales (K Pcs), 2022-2027
Table 18. By Application - United States Next Generation Cancer Diagnostic Devices Revenue, (US$, Mn), 2021 VS 2027
Table 19. By Application - United States Next Generation Cancer Diagnostic Devices Revenue (US$, Mn), 2016-2021
Table 20. By Application - United States Next Generation Cancer Diagnostic Devices Revenue (US$, Mn), 2022-2027
Table 21. By Application - United States Next Generation Cancer Diagnostic Devices Sales (K Pcs), 2016-2021
Table 22. By Application - United States Next Generation Cancer Diagnostic Devices Sales (K Pcs), 2022-2027
Table 23. Roche Holding Ltd.?Switzerland) Corporation Information
Table 24. Roche Holding Ltd.?Switzerland) Description and Major Businesses
Table 25. Roche Holding Ltd.?Switzerland) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 26. Roche Holding Ltd.?Switzerland) Next Generation Cancer Diagnostic Devices Product
Table 27. Roche Holding Ltd.?Switzerland) Recent Developments
Table 28. Abbott Laboratories(US) Corporation Information
Table 29. Abbott Laboratories(US) Description and Major Businesses
Table 30. Abbott Laboratories(US) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 31. Abbott Laboratories(US) Next Generation Cancer Diagnostic Devices Product
Table 32. Abbott Laboratories(US) Recent Developments
Table 33. Siemens Healthcare(Germany) Corporation Information
Table 34. Siemens Healthcare(Germany) Description and Major Businesses
Table 35. Siemens Healthcare(Germany) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 36. Siemens Healthcare(Germany) Next Generation Cancer Diagnostic Devices Product
Table 37. Siemens Healthcare(Germany) Recent Developments
Table 38. Agilent Technologies Inc(Germany) Corporation Information
Table 39. Agilent Technologies Inc(Germany) Description and Major Businesses
Table 40. Agilent Technologies Inc(Germany) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 41. Agilent Technologies Inc(Germany) Next Generation Cancer Diagnostic Devices Product
Table 42. Agilent Technologies Inc(Germany) Recent Developments
Table 43. Illumina Inc.(US) Corporation Information
Table 44. Illumina Inc.(US) Description and Major Businesses
Table 45. Illumina Inc.(US) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 46. Illumina Inc.(US) Next Generation Cancer Diagnostic Devices Product
Table 47. Illumina Inc.(US) Recent Developments
Table 48. Becton Dickinson and Co.(US) Corporation Information
Table 49. Becton Dickinson and Co.(US) Description and Major Businesses
Table 50. Becton Dickinson and Co.(US) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 51. Becton Dickinson and Co.(US) Next Generation Cancer Diagnostic Devices Product
Table 52. Becton Dickinson and Co.(US) Recent Developments
Table 53. QIAGEN N.V.(Germany) Corporation Information
Table 54. QIAGEN N.V.(Germany) Description and Major Businesses
Table 55. QIAGEN N.V.(Germany) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 56. QIAGEN N.V.(Germany) Next Generation Cancer Diagnostic Devices Product
Table 57. QIAGEN N.V.(Germany) Recent Developments
Table 58. Affymetrix Inc.(US) Corporation Information
Table 59. Affymetrix Inc.(US) Description and Major Businesses
Table 60. Affymetrix Inc.(US) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 61. Affymetrix Inc.(US) Next Generation Cancer Diagnostic Devices Product
Table 62. Affymetrix Inc.(US) Recent Developments
Table 63. Johnson & Johnson(US) Corporation Information
Table 64. Johnson & Johnson(US) Description and Major Businesses
Table 65. Johnson & Johnson(US) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 66. Johnson & Johnson(US) Next Generation Cancer Diagnostic Devices Product
Table 67. Johnson & Johnson(US) Recent Developments
Table 68. Thermo Fisher Scientific Inc.(US) Corporation Information
Table 69. Thermo Fisher Scientific Inc.(US) Description and Major Businesses
Table 70. Thermo Fisher Scientific Inc.(US) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 71. Thermo Fisher Scientific Inc.(US) Next Generation Cancer Diagnostic Devices Product
Table 72. Thermo Fisher Scientific Inc.(US) Recent Developments
Table 73. GE Healthcare(England) Corporation Information
Table 74. GE Healthcare(England) Description and Major Businesses
Table 75. GE Healthcare(England) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 76. GE Healthcare(England) Next Generation Cancer Diagnostic Devices Product
Table 77. GE Healthcare(England) Recent Developments
Table 78. Life Technologies Corp.(US) Corporation Information
Table 79. Life Technologies Corp.(US) Description and Major Businesses
Table 80. Life Technologies Corp.(US) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 81. Life Technologies Corp.(US) Next Generation Cancer Diagnostic Devices Product
Table 82. Life Technologies Corp.(US) Recent Developments
Table 83. Luminex Corp.(US) Corporation Information
Table 84. Luminex Corp.(US) Description and Major Businesses
Table 85. Luminex Corp.(US) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 86. Luminex Corp.(US) Next Generation Cancer Diagnostic Devices Product
Table 87. Luminex Corp.(US) Recent Developments
Table 88. Cepheid Inc.(US) Corporation Information
Table 89. Cepheid Inc.(US) Description and Major Businesses
Table 90. Cepheid Inc.(US) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 91. Cepheid Inc.(US) Next Generation Cancer Diagnostic Devices Product
Table 92. Cepheid Inc.(US) Recent Developments
Table 93. Allegro Diagnostics Corp.(Brazil) Corporation Information
Table 94. Allegro Diagnostics Corp.(Brazil) Description and Major Businesses
Table 95. Allegro Diagnostics Corp.(Brazil) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 96. Allegro Diagnostics Corp.(Brazil) Next Generation Cancer Diagnostic Devices Product
Table 97. Allegro Diagnostics Corp.(Brazil) Recent Developments
Table 98. Next Generation Cancer Diagnostic Devices Production Capacity (K Pcs) of Key Manufacturers in United States Market, 2019-2021 (K Pcs)
Table 99. United States Next Generation Cancer Diagnostic Devices Capacity Market Share of Key Manufacturers, 2019-2021
Table 100. Next Generation Cancer Diagnostic Devices Market Opportunities & Trends in United States Market
Table 101. Next Generation Cancer Diagnostic Devices Market Drivers in United States Market
Table 102. Next Generation Cancer Diagnostic Devices Market Restraints in United States Market
Table 103. Next Generation Cancer Diagnostic Devices Raw Materials
Table 104. Next Generation Cancer Diagnostic Devices Raw Materials Suppliers in United States Market
Table 105. Typical Next Generation Cancer Diagnostic Devices Downstream
Table 106. Next Generation Cancer Diagnostic Devices Downstream Clients in United States Market
Table 107. Next Generation Cancer Diagnostic Devices Distributors and Sales Agents in United States Market
List of Figures
Figure 1. Next Generation Cancer Diagnostic Devices Product Picture
Figure 2. Next Generation Cancer Diagnostic Devices Segment by Type
Figure 3. Next Generation Cancer Diagnostic Devices Segment by Application
Figure 4. United States Next Generation Cancer Diagnostic Devices Market Overview: 2020
Figure 5. United States Next Generation Cancer Diagnostic Devices Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. United States Next Generation Cancer Diagnostic Devices Revenue, 2016-2027 (US$, Mn)
Figure 7. Next Generation Cancer Diagnostic Devices Sales in United States Market: 2016-2027 (K Pcs)
Figure 8. The Top 3 and 5 Players Market Share by Next Generation Cancer Diagnostic Devices Revenue in 2020
Figure 9. Next Generation Sequencing Product Picture
Figure 10. qPCR & Multiplexing Product Picture
Figure 11. Lab-on- a- chip (LOAC) Product Picture
Figure 12. Protein Microarrays Product Picture
Figure 13. DNA Microarrays Product Picture
Figure 14. By Type - United States Next Generation Cancer Diagnostic Devices Sales Market Share, 2016-2027
Figure 15. By Type - United States Next Generation Cancer Diagnostic Devices Revenue Market Share, 2016-2027
Figure 16. By Type - United States Next Generation Cancer Diagnostic Devices Price (USD/Pcs), 2016-2027
Figure 17. Biomarker Development
Figure 18. CTC Analysis
Figure 19. Proteomic Analysis
Figure 20. Epigenetic Analysis
Figure 21. Genetic Analysis
Figure 22. By Application - United States Next Generation Cancer Diagnostic Devices Sales Market Share, 2016-2027
Figure 23. By Application - United States Next Generation Cancer Diagnostic Devices Revenue Market Share, 2016-2027
Figure 24. By Application - United States Next Generation Cancer Diagnostic Devices Price (USD/Pcs), 2016-2027
Figure 25. Roche Holding Ltd.?Switzerland) Next Generation Cancer Diagnostic Devices Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 26. Abbott Laboratories(US) Next Generation Cancer Diagnostic Devices Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 27. Siemens Healthcare(Germany) Next Generation Cancer Diagnostic Devices Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 28. Agilent Technologies Inc(Germany) Next Generation Cancer Diagnostic Devices Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 29. Illumina Inc.(US) Next Generation Cancer Diagnostic Devices Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 30. Becton Dickinson and Co.(US) Next Generation Cancer Diagnostic Devices Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 31. QIAGEN N.V.(Germany) Next Generation Cancer Diagnostic Devices Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 32. Affymetrix Inc.(US) Next Generation Cancer Diagnostic Devices Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 33. Johnson & Johnson(US) Next Generation Cancer Diagnostic Devices Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 34. Thermo Fisher Scientific Inc.(US) Next Generation Cancer Diagnostic Devices Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 35. GE Healthcare(England) Next Generation Cancer Diagnostic Devices Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 36. Life Technologies Corp.(US) Next Generation Cancer Diagnostic Devices Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 37. Luminex Corp.(US) Next Generation Cancer Diagnostic Devices Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Cepheid Inc.(US) Next Generation Cancer Diagnostic Devices Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Allegro Diagnostics Corp.(Brazil) Next Generation Cancer Diagnostic Devices Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. United States Next Generation Cancer Diagnostic Devices Production Capacity (K Pcs), 2016-2027
Figure 41. Next Generation Cancer Diagnostic Devices Industry Value Chain
Figure 42. Marketing Channels

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs